Originally developed to monitor B cells producing antigen- or pathogen-specific antibodies, the ELISpot assay is widely used for evaluating vaccine-induced wanted immunogenicity. However, thanks to its high sensitivity, it is also a valuable tool for investigating unwanted immunogenicity, expanding its applications beyond traditional vaccine research. Early Applications in Preclinical…